JWM
RVMD icon

JPL Wealth Management’s Revolution Medicines RVMD Stock Holding History

JPL Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Buy
+332
New +$33.5K 0.01% 312
2025
Q4 		– Sell
-142
Closed -$6.63K – 920
2025
Q3 		$6.63K Buy
+142
New +$5.56K ﹤0.01% 611

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JPL Wealth Management's RVMD Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Revolution Medicines (RVMD) in Q1 2026: 332 shares worth $32.3K. The stake represents 0.01% of the portfolio and ranks #312 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in RVMD as recently as Q3 2025.

JPL Wealth Management first reported a position in RVMD in Q3 2025 and has held it in 2 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • JPL Wealth Management held 332 shares of Revolution Medicines worth $32.3K as of Q1 2026.
  • Revolution Medicines was a new JPL Wealth Management position in Q1 2026.
  • Revolution Medicines made up 0.01% of JPL Wealth Management's portfolio in Q1 2026, its #312 holding.
  • JPL Wealth Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 2 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.